Protagenic Therapeutics, Inc. (PTIX)

Protagenic Therapeutics Statistics

Total Valuation

PTIX has a market cap or net worth of $8.22 million. The enterprise value is $8.13 million.

Market Cap	8.22M
Enterprise Value	8.13M

Important Dates

The last earnings date was Wednesday, September 10, 2025, after market close.

Earnings Date	Sep 10, 2025
Ex-Dividend Date	n/a

Share Statistics

PTIX has 1.91 million shares outstanding. The number of shares has increased by 28.54% in one year.

Current Share Class	1.91M
Shares Outstanding	1.91M
Shares Change (YoY)	+28.54%
Shares Change (QoQ)	+18.30%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	4.05%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.48% in the last 52 weeks. The beta is 0.38, so PTIX's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-47.48%
50-Day Moving Average	3.34
200-Day Moving Average	4.28
Relative Strength Index (RSI)	63.31
Average Volume (20 Days)	106,733

Short Selling Information

The latest short interest is 46,166, so 2.41% of the outstanding shares have been sold short.

Short Interest	46,166
Short Previous Month	89,908
Short % of Shares Out	2.41%
Short % of Float	n/a
Short Ratio (days to cover)	0.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	-3.63M
FCF Per Share	-$1.89

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PTIX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.54%
Shareholder Yield	-28.54%
Earnings Yield	n/a
FCF Yield	-44.13%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a